Chronomodulated irinotecan (I), fluorouracil (F), leucovorin (L), and oxaliplatin (O) (chrono IFLO) as salvage therapy in oxaliplatin- and irinotecan-resistant advanced colorectal cancer (ACRC): ...
Dublin, Aug. 08, 2019 (GLOBE NEWSWIRE) -- The "Radiotherapy - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering. Radiotherapy market worldwide is ...
Results from the NRG Oncology RTOG 0631 clinical trial comparing stereotactic vs. conventional radiotherapy for localized vertebral metastases of the spine did not meet its primary endpoint. Data from ...
ARLINGTON, Va., October 24, 2021 — People with liver cancer awaiting transplantation could benefit from non-invasive radiation treatments but are rarely given this therapy, according to a new analysis ...
In radiation therapy, the accuracy of the set up and positioning of a patient before treatment delivery determines the efficacy of treatment. This interactive E-learning Module will focus on key steps ...
TBCRC 019: An open-label, randomized, phase II trial of nanoparticle albumin-bound paclitaxel with or without the anti-death receptor 5 (DR5) monoclonal antibody tigatuzumab in patients with ...
Doctors may use radiation therapy to treat benign tumors. Radiation can shrink and eliminate benign growths without doctors having to perform surgery. Benign tumors are noncancerous growths that can ...
Opportunities in the radiation oncology market arise from increasing cancer incidences, expanding treatment centers, and ...
Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results